Skip to Content

MYLAN 2150 (Meclofenamate 50 mg)

Pill imprint MYLAN 2150 has been identified as Meclofenamate sodium 50 mg.

Meclofenamate is used in the treatment of period pain; premenstrual dysphoric disorder; pain; rheumatoid arthritis; osteoarthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. FDA has not classified the drug for risk during pregnancy. Meclofenamate 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Meclofenamate sodium 50 mg MYLAN 2150
Meclofenamate sodium 50 mg MYLAN 2150  Front
Meclofenamate sodium 50 mg MYLAN 2150  Back
Meclofenamate sodium 50 mg MYLAN 2150
Meclofenamate sodium
Imprint:
MYLAN 2150
Strength:
50 mg
Color:
Red
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2150
Inactive Ingredients:
silicon dioxide
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
FD&C Red No. 3
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide